1. Proteoglycans as miscommunication biomarkers for cancer diagnosis
   Lingling Xu et al, 2019, Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A CrossRef
2. The Role of Glypicans in Cancer Progression and Therapy
   Nan Li et al, 2020, Journal of Histochemistry & Cytochemistry CrossRef
3. GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion
   Xin Yang et al, 2021, Oncogene CrossRef
4. Heparan sulfate signaling in cancer
   Erik H. Knelson et al, 2014, Trends in Biochemical Sciences CrossRef
5. Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes
   Victor Chérouvrier Hansson et al, 2024, International Journal of Molecular Sciences CrossRef
6. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
   Noemi Veraldi et al, 2020, Molecules CrossRef
7. EGFR-Dependent Extracellular Matrix Protein Interactions Might Light a Candle in Cell Behavior of Non-Small Cell Lung Cancer
   Sarah Sayed Hassanein et al, 2021, Frontiers in Oncology CrossRef
8. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma
   S Yuan et al, 2016, Oncogene CrossRef
9. Proteoglycans and Glycosaminoglycans in Cancer
   Giovani Bravin Peres et al, 2023, Handbook of Cancer and Immunology CrossRef
10. Glypicans as Cancer Therapeutic Targets
    Nan Li et al, 2018, Trends in Cancer CrossRef
11. miR‐297 acts as an oncogene by targeting GPC5 in lung adenocarcinoma
    Yunchuan Sun et al, 2016, Cell Proliferation CrossRef
12. Heparan sulfate proteoglycans in cancer: Pathogenesis and therapeutic potential
    Hua Yang et al, 2023, Novel Methods and Pathways in Cancer Glycobiology Research CrossRef
13. MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/β-catenin signaling via targeting Glypican-5
    Xin Hong et al, 2019, European Journal of Pharmacology CrossRef
14. Prognostic Value of GPC5 Polymorphism rs2352028 and Clinical Characteristics in Chinese Lung Cancer Patients
    Fan Wang et al, 2022, Future Oncology CrossRef
15. Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth
    Nhat D. Quach et al, 2019, Scientific Reports CrossRef
16. Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
    Arvindhan Nagarajan et al, 2018, Frontiers in Endocrinology CrossRef
17. Glypican-1 in human glioblastoma: implications in tumorigenesis and chemotherapy
    Eduardo Listik et al, 2020, Oncotarget CrossRef
18. Subcellular localization of glypican-5 is associated with dynamic motility of the human mesenchymal stem cell line U3DT
    Masao Takeuchi et al, 2021, PLOS ONE CrossRef
19. Extracellular matrix functions in lung cancer
    Martin Götte et al, 2018, Matrix Biology CrossRef
20. Epigenetic priming by EHMT1/EHMT2 in acute lymphoblastic leukemia induces TP53 and TP73 overexpression and promotes cell death
    Amandda Évelin Silva-Carvalho et al, 2020, Toxicology in Vitro CrossRef
21. Glypican-5 is a tumor suppressor in non-small cell lung cancer cells
    Lixia Guo et al, 2016, Biochemistry and Biophysics Reports CrossRef
22. Determination of the target proteins in chemotherapy resistant breast cancer stem cell-like cells by protein array
    Meltem Demirel Kars et al, 2019, European Journal of Pharmacology CrossRef